1Roles
analysisWojcicki joined the board of 23andMe, Inc. and co-founded it in 2006 and was its chief executive from 2010; she became chair of the holding company effective June 16, 2021 and in July 2024 was its chair and chief executive. On March 21, 2025, by agreement with the Special Committee, she resigned as chief executive and president from March 23 and as chair, remaining a director, and left her posts at the subsidiaries. Her fiscal-2024 compensation was $7,363,723, almost all stock options. Company filings list her earlier work as a healthcare analyst and her other boards, including Zipline and, until 2022, Cazoo, whose seat an aggregator ends on February 27, 2023. 1 2 3 4 5 6 7
sources in this section
- 23andMe Holding Co. definitive proxy statement for the 2024 annual meeting U.S. Securities and Exchange Commission (EDGAR) · Jul 2024
- Chrome Holding Co. Form 10-K/A for the fiscal year ended March 31, 2025 (Part III) U.S. Securities and Exchange Commission (EDGAR) · 2025
- 23andMe Holding Co. Form 8-K on the closing of the business combination (event of June 16, 2021) U.S. Securities and Exchange Commission (EDGAR) · Jun 2021
- 23andMe Holding Co. Form 8-K reporting the Chapter 11 filing (event of March 21, 2025) U.S. Securities and Exchange Commission (EDGAR) · 24 Mar 2025
- Disclosure statement for the joint plan of Chrome Holding Co. and its debtor affiliates, Exhibit 99.2 to Form 8-K U.S. Securities and Exchange Commission (EDGAR) · Aug 2025
- Court record source · src-031 identified by category only · Court record
- Other source · src-030 identified by category only · Other
2Voting control
analysisThrough ABeeC 2.0, LLC, of which her revocable trust is the sole member and she the sole trustee, Wojcicki held 30.67% of the vote after the 2021 merger and 49.75% on July 1, 2024, before the 1-for-20 reverse split. In June 2025 ABeeC converted its Class B shares, and on July 1, 2025 she held 22.56% of the Class A stock and 12.33% of the vote. Co-founder Linda Avey wrote in March 2025 that Wojcicki had "architected a majority vote for herself"; that is Avey's personal account, and the company did not immediately respond to the outlet that reported it. 1 2 3 4
sources in this section
- 23andMe Holding Co. Form 8-K on the closing of the business combination (event of June 16, 2021) U.S. Securities and Exchange Commission (EDGAR) · Jun 2021
- 23andMe Holding Co. definitive proxy statement for the 2024 annual meeting U.S. Securities and Exchange Commission (EDGAR) · Jul 2024
- Chrome Holding Co. Form 10-K/A for the fiscal year ended March 31, 2025 (Part III) U.S. Securities and Exchange Commission (EDGAR) · 2025
- Media source · src-112 identified by category only · Media
3The buyout proposals
analysisIn April 2024 she said she was considering taking the company private and would not support an alternative transaction; the Special Committee rejected her $0.40-a-share proposal of July 29, 2024 ($8.00 after the reverse split) as offering no premium and lacking financing. After the independent directors resigned in September 2024 she was briefly the sole director. In 2025 her joint $2.53 proposal with New Mountain Capital lapsed when New Mountain withdrew, and the committee rejected her offers of $0.41 a share, the last with contingent value rights. 1 2 3
sources in this section
- Court record source · src-031 identified by category only · Court record
- Disclosure statement for the joint plan of Chrome Holding Co. and its debtor affiliates, Exhibit 99.2 to Form 8-K U.S. Securities and Exchange Commission (EDGAR) · Aug 2025
- Schedule 13D Amendment No. 12 filed by Anne Wojcicki and affiliates regarding 23andMe Holding Co. U.S. Securities and Exchange Commission (EDGAR) · Mar 2025
4TTAM and the purchase
analysisThe court found that she created TTAM Research Institute soon after the filing to buy the assets, a non-profit public-benefit corporation fully funded by her and her affiliates, of which she is chief executive, president and one of three directors. Approving the sale, it found that even treating her as an insider she would not benefit unfairly because she was investing more than $300 million of her own funds and would own a non-profit, and it described the deal as her repurchase of a business she co-founded and ran. A 2026 conference profile calls her the Institute's founder and chief executive. 1 2
sources in this section
- Memorandum opinion on the sale of the debtors' assets to TTAM Research Institute U.S. Bankruptcy Court, E.D. Mo.
- Other source · src-068 identified by category only · Other
5Under the plan
analysisThe plan names her as an Excluded Party, not released and open to suit by the trust, and states that she is not an affiliate of the debtors; exclusion is not a finding of liability. The confirmation order treats her, her foundation and ABeeC as having opted out of the releases while preserving their indemnification and exculpation rights. On January 3, 2026 she applied for payment of her unliquidated indemnification expenses as an administrative expense; the record does not show the ruling. 1 2 3
sources in this section
- Order confirming the modified fifth amended joint plan, Exhibit 2.1 to Form 8-K U.S. Securities and Exchange Commission (EDGAR) · 1 Dec 2025
- Company statement source · src-045 identified by category only · Company statement
- Court record source · src-051 identified by category only · Court record
Recorded connections
- Anne Wojcicki to Chrome Holding Co. (formerly 23andMe Holding Co.)Chief executive officer and presidentdocumented · From the June 16, 2021 closing until 5:00 p.m. ET on March 23, 2025 · historical
- Anne Wojcicki to Chrome Holding Co. (formerly 23andMe Holding Co.)Director (chair from June 16, 2021 until March 21, 2025; sole director from September 17 to October 28, 2024; non-independent Class III director)documented · Elected at the June 10, 2021 VGAC meeting, effective at the June 16, 2021 closing; sole director September 17 – October 28, 2024; still a director in July 2025 · historical
- Anne Wojcicki to Chrome Holding Co. (formerly 23andMe Holding Co.)Beneficial owner of shares carrying a large share of the vote, directly and through ABeeC 2.0, LLC, her revocable trust and her foundation (30.67% of the vote after the merger, 49.75% on July 1, 2024, 12.33% on July 1, 2025)documented · From June 16, 2021; about 49% with affiliates when the Special Committee was formed in March 2024; reduced after the June 2025 conversion of the Class B shares · historical
- Anne Wojcicki to Chrome Holding Co. (formerly 23andMe Holding Co.)Bidder in take-private proposals for the company, which the Special Committee did not acceptdocumented · April 2024 – March 2025 · historical
- Anne Wojcicki to Chrome Holding Co. (formerly 23andMe Holding Co.)Announced $25 million investment in the PIPE accompanying the mergerdocumented · Announced February 4, 2021 · historical
- Anne Wojcicki to Chrome Holding Co. (formerly 23andMe Holding Co.)Excluded Party under the plan (not released; the trust may bring claims); holder of Class 12 equity interests whose indemnification rights are preserveddocumented · Plan confirmed December 1, 2025 · current or historical not established
- Anne Wojcicki to Chrome Holding Co. (formerly 23andMe Holding Co.)Applicant for payment of her indemnification expenses as an administrative expense of the estatesdocumented · Application of January 3, 2026 · current or historical not established
- Anne Wojcicki to ABeeC 2.0, LLCControls the LLC as sole trustee of its sole member and votes and disposes of its sharesdocumented · From 2021 · current or historical not established
- Anne Wojcicki to Anne Wojcicki FoundationPresident and chair of the board; shares voting and dispositive power over the foundation's sharesdocumented · As of 2024–2025 · current or historical not established
- Anne Wojcicki to ChromeCo, Inc. (formerly 23andMe, Inc.)Co-founder; director from 2006 and chief executive officer from 2010documented · 2006 – March 21, 2025 (resigned as director and officer) · historical
- Anne Wojcicki to Zipline International, Inc.Member of the board of directorsdocumented · From September 2021 (announcement) · current or historical not established
- Anne Wojcicki to AJAX IDirector of the blank check companydocumented · 2020 – 2021 · historical
- Anne Wojcicki to Cazoo Group Ltd.Directordocumented · 2021 – 2022 · historical
- Anne Wojcicki to The Anne Wojcicki Revocable Trust U/A/D 9/2/09Sole trusteedocumented · As of 2024–2025 · current or historical not established
- Anne Wojcicki to 23andMe Research Institute (formerly TTAM Research Institute)Creator, funder with her affiliates, chief executive officer, president and one of three directorsdocumented · From 2025 (formed soon after the March 23, 2025 petitions) · current at the evidence cutoff
- Anne Wojcicki to Lemonaid Health, Inc.Director and officerdocumented · Until March 21, 2025 · historical
- Anne Wojcicki to Chrome Pharmacy Holdings, Inc. (formerly 23andMe Pharmacy Holdings, Inc.)Officerdocumented · Until March 21, 2025 · historical
- Anne Wojcicki to Lemonaid Pharmacy Holdings Inc.Officerdocumented · Until March 21, 2025 · historical
- Anne Wojcicki to New Mountain Capital L.L.C.Joint bidder with New Mountain Capital at $2.53 a share; New Mountain withdrewdocumented · February 20 – March 3, 2025 · historical
- Anne Wojcicki to Kaiser Permanente Bernard J. Tyson School of MedicineBoard memberdocumented · As listed in 2021–2025 filings · current or historical not established
- Anne Wojcicki to Breakthrough Prize in Life SciencesCo-founder and board memberdocumented · As listed in 2021–2025 filings · current or historical not established
- Anne Wojcicki to Blok24, Inc.Board member (as listed by an aggregator)reported · Undated aggregator listing · current or historical not established
- Anne Wojcicki to Foundation for the National Institutes of Health, Inc.Board memberdocumented · 2008 – 2016 · historical
- Anne Wojcicki to Sidecar Health, Inc.Member of the board of advisors (not the board of directors)documented · Undated website listing · current or historical not established
- Susan Wojcicki and Anne WojcickiSisterdocumented · Stated in the company filings · current or historical not established
- Anne Wojcicki to Passport Capital, LLCHealthcare analystdocumented · 2004 – 2006 · historical
- Anne Wojcicki to Andor Capital ManagementHealthcare analystdocumented · 2001 – 2002 · historical
- Anne Wojcicki to Ardsley PartnersHealthcare analystdocumented · 1999 – 2000 · historical
- Anne Wojcicki to Investor ABHealthcare analystdocumented · 1996 – 1999 · historical